AlloVir, Inc.

ALVR · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$58,769-$190,418-$168,710-$171,962
Dep. & Amort.$0$398$723$189
Deferred Tax$0$0$0$1,197
Stock-Based Comp.$26,347$40,779$41,315$43,975
Change in WC-$25,305$2,025-$16,146$19,354
Other Non-Cash-$9,978$22,765$766$928
Operating Cash Flow-$67,705-$124,451-$142,052-$106,319
Investing Activities
PP&E Inv.$0$0$104-$26
Net Acquisitions$0$0$0-$186
Inv. Purchases$0-$125,827-$228,806-$76,591
Inv. Sales/Matur.$95,000$163,812$148,328$262,600
Other Inv. Act.$0$0-$104$186
Investing Cash Flow$95,000$37,985-$80,478$185,983
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$21$70,169$126,425$232
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$21$326$536$232
Financing Cash Flow$21$70,495$126,961$232
Forex Effect$0$0$0-$44
Net Chg. in Cash$27,316-$15,971-$95,569$79,852
Supplemental Information
Beg. Cash$90,973$106,944$202,513$122,661
End Cash$118,289$90,973$106,944$202,513
Free Cash Flow-$67,705-$124,451-$141,948-$106,345